* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download AFLUID June 47/6 - AJP
Metalloprotein wikipedia , lookup
Citric acid cycle wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Magnesium transporter wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Peptide synthesis wikipedia , lookup
Butyric acid wikipedia , lookup
Point mutation wikipedia , lookup
Specialized pro-resolving mediators wikipedia , lookup
15-Hydroxyeicosatetraenoic acid wikipedia , lookup
Genetic code wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Am J Physiol Renal Physiol 278: F999–F1005, 2000. Amino acid transport in podocytes JOACHIM GLOY,1 STEFFEN REITINGER,1 KARL-GEORG FISCHER,1 RAINER SCHREIBER,2 ANISSA BOUCHEROT,2 KARL KUNZELMANN,2 PETER MUNDEL,3 AND HERMANN PAVENSTÄDT1 1Department of Medicine, Division of Nephrology, and 2Department of Physiology, Albert-Ludwigs-University Freiburg, D-79106 Freiburg, Germany; and 3Department of Medicine and Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York podocytes; amino acid transport; puromycin THE PODOCYTE is a highly specialized cell, forming multiple interdigitating foot processes that are interconnected by slit diaphragms and cover the exterior basement membrane surface area of the glomerular capillary. The contractile filaments in the foot processes of podocytes stabilize the glomerular architecture by antagonizing the distending forces of the capillaries, and they may modulate glomerular filtration rate by changing the ultrafiltration coefficient Kf (19). Damage to the The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ‘‘advertisement’’ in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. http://www.ajprenal.org podocyte leads to proteinuria, and in several proteinuric diseases the podocyte is the target cell of injury (18). It has been suggested that the maintenance of the differentiated podocyte structure requires a complex intracellular pumping and trafficking of proteins through systems similar to those that operate in other highly differentiated cells such as neurons (18, 26). Uptake of amino acids (AA) is essential for many cellular processes like protein synthesis, hormone metabolism, regulation of cell growth, and osmotic volume changes (5, 26, 29). Different AA transport (AAT) systems for neutral, acidic, and basic AA have been characterized in regard to their substrate specificity, cotransport properties, and tissue distribution, and 20 of these AAT have been cloned already (21, 23, 24). Very recently, it has been shown that the formation of podocyte processes is highly dependent on a constant fresh source of lipid and proteins (30). Therefore, AAT may play a critical role in maintaining the differentiated structure of the podocyte. The purpose of the present study was to investigate properties of AAT in mouse podocytes. As a first step, we characterized AAT in podocytes and investigated mRNA expression of various AAT by means of RT-PCR. We then studied whether podocyte injury by puromycin aminonucleoside (PA) may be associated with a disturbed AAT. PA nephrosis is a well-established experimental model for minimal change disease, which is characterized by effacement of podocyte foot processes from the glomerular basement membrane and massive proteinuria (18, 33). Although the mechanisms of podocyte injury in PA nephrosis are presently not clear, it is likely that basic cellular functions such as AAT are affected. METHODS Cell culture. Cultivation of conditionally immortalized mouse podocytes was done as recently reported (25). In brief, podocytes were maintained in RPMI-1640 medium (Life Technologies) supplemented with 10% FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin. To propagate podocytes, cells were cultivated at 33°C (permissive conditions), and culture medium was supplemented with 10 U/ml mouse recombinant g-interferon (Sigma Chemical) to enhance expression of the T-antigen. To induce differentiation, podocytes were maintained on type I collagen at 37°C without g-interferon (nonpermissive conditions). A detailed characterization of these cells has been published previously (25). For experi- 0363-6127/00 $5.00 Copyright r 2000 the American Physiological Society F999 Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 Gloy, Joachim, Steffen Reitinger, Karl-Georg Fischer, Rainer Schreiber, Anissa Boucherot, Karl Kunzelmann, Peter Mundel, and Hermann Pavenstädt. Amino acid transport in podocytes. Am J Physiol Renal Physiol 278: F999–F1005, 2000.—It has recently been shown that formation of podocyte foot processes is dependent on a constant source of lipids and proteins (Simons M, Saffrich R, Reiser J, and Mundel P. J Am Soc Nephrol 10: 1633–1639, 1999). Here we characterize amino acid transport mechanisms in differentiated cultured podocytes and investigate whether it may be disturbed during podocyte injury. RT-PCR studies detected mRNA for transporters of neutral amino acids (ASCT1, ASCT2, and B0/1), cationic AA (CAT1 and CAT3), and anionic AA (EAAT2 and EAAT3). Alanine (Ala), asparagine, cysteine (Cys), glutamine (Gln), glycine (Gly), leucine (Leu), methionine (Met), phenylalanine (Phe), proline (Pro), serine (Ser), threonine (Thr), glutamic acid (Glu), arginine (Arg), and histidine (His) depolarized podocytes and increased their whole cell conductances. Depletion of extracellular Na1 completely inhibited the depolarization induced by Ala, Gln, Glu, Gly, Leu, and Pro and decreased the depolarization induced by Arg and His, indicating the presence of Na1-dependent amino acid transport. Incubation of podocytes with 100 µg/ml puromycin aminonucleoside for 24 h significantly attenuated the effects induced by the various amino acids by ,70%. The data indicate the existence of different amino acid transporter systems in podocytes. Alteration of amino acid transport may participate in podocyte injury and disturbed foot process formation. F1000 AMINO ACID TRANSPORT IN PODOCYTES GAATCAG, r-TGAGTTGGGGACATGAGTGA; product size: 259 bp); 4) mouse mNBAT (B0,1; AA509386; f-GGATGAGGACAAAGGCAAGA, r-ATGAGCAGGAACACGGAAAC; product size: 298 bp); 5) mouse insulin-activated AA transporter mIAT (L42115; f-TCGCTATCGTCTTTGGTGTG, r-GTATTTCCCGAGGCTGATGA; product size: 206 bp); 6) mouse cationic AA transporter mCAT1 (AA061682; f-GAAGACTCCGTTCCTGTGTTG, r-ACCTGACCCTGCTAC-GCTTT; product size: 368 bp); 7) mouse mCAT2 (L11600; f-TACGTCCAGTGTCGCAAGAG, r-CAACGTCCCTGTAAAGCCAT; product size: 397 bp); 8) mouse mCAT3 (U70859; f-ACGGCACTTGTA-GCTTGGAC, r-AATGGACACCAGGGAGTGAG; product size: 575 bp); 9) mouse excitatory AA transporter 1 (mEAAT1; AA553011; f-TCCCATCCCAGAGTCAGAAA, r-ATGACAGCAGTGACCGTGAG; product size: 295 bp); 10) mouse mEAAT2 (U11763; f-AGTGCTGGAACT-TTGCCTGT, r-GGACTGCGTCTTGGTCATTT; product size: 1719 bp); and 11) human hEAAT3 (AA084131; f-TCCCTAAACCCAGAGAACCA, rAAGTCAACATCGTGAACCCC; product size: 455 bp). PCRamplification of RT reactions without RT revealed no PCR product, thereby excluding amplification of genomic DNA. RT and PCR amplification were repeated in the same manner by using four different mouse podocyte RNA samples. In addition, three different mouse glomeruli RNA samples were analyzed for the PCR products in the same way. Isolation and preparation of glomeruli have been described in a previous report (10). Chemicals. The following agents were used. Dimethylsulfoxide was from Merck (Darmstadt, Germany). PA and all L-amino acids used were obtained from Sigma Chemical (Deisenhofen, Germany) and Calbiochem (San Diego, CA) in the highest grade of purity available. Statistics. The data are given as mean values 6 SE; n refers to the number of experiments. A paired t-test was used to compare mean values within one experimental series. A P value ,0.05 was accepted to indicate statistical significance. RESULTS Identification of AAT systems in mouse podocytes by RT-PCR. Figure 1 shows ethidium bromide-stained agarose gel electrophoreses of PCR products for different AAT systems in mouse podocytes. In mouse podocytes positive expression of mRNA for the neutral AAT systems ASCT1, ASCT2, IAT, and B0/1, the cationic AAT systems CAT1 and CAT3, and the anionic AAT systems EAAT2 and EAAT3 could be detected. mRNA for all these AAT systems could be amplified also in isolated mouse glomeruli (n 5 3, data not shown). Additionally, in mouse glomeruli mRNA for the AAT systems EAAT1 and CAT2 were detected, which could not be amplified in podocytes. AA depolarize Vm and increase Gm in podocytes. Podocytes had a Vm of 264 6 1 mV (n 5 169). Podocytes were reversibly depolarized by a large number of AA. Addition of alanine (Ala; 5 mM) to the bath caused a rapid and reversible depolarization of podocytes by 32 6 1 mV that was accompanied by an increase in Gm from 1.3 6 0.3 to 1.8 6 0.3 nS (n 5 13). Figure 2 gives a representative original recording for the effect of Ala on Vm and Gm. Figure 3 shows the concentration response curves for the depolarizing effect induced by different AA with a maximal depolarization of 41 6 2 mV (n 5 9) induced by 50 mM of Ala. Similar to Ala, the neutral AA methionine (Met), leucine (Leu), phenylalanine (Phe), Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 ments, cells between passage 15 and 25 were seeded at 37°C into 6-well plates and cultured in standard RPMI media containing 1% FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin for at least 7 days until cells were differentiated. Patch-clamp experiments The patch-clamp method (slow whole cell configuration) used in these experiments has been described previously (11, 14). In brief, podocytes were mounted in a bath chamber on the stage of an inverted microscope, kept at 37°C, and superfused with a phosphate-buffered Ringer-like solution. In ion-replacement studies Na1 was replaced by N-methyl-D-glucamine1(NMDG1). Pipettes were filled with a solution containing (in mM) 95 K-gluconate, 30 KCl, 4.8 Na2HPO4, 1.2 NaH2PO4, 0.73 Ca gluconate, 1.03 MgCl2, 1 EGTA, and 5 D-glucose, pH 7.2, as well as 1027 M Ca21 activity, to which 100–300 mg/l nystatin were added. The patch pipettes had an input resistance of 2–3 MV. A flowing (10 µl/h) KCl (2 M) electrode was used as a reference. The data were recorded by using a patch-clamp amplifier (Fröbe and Busche, Physiologisches Institut, Freiburg, Germany) and continuously displayed on a pen recorder. The access conductance (Ga) was monitored in most of the experiments by the method recently described. Membrane voltage (Vm) of the cells was recorded continuously by using the current-clamp mode of the patch-clamp amplifier. To obtain the whole cell conductance (Gm), the voltage of the respective cell was clamped in the voltage clamp mode (Vc) to Vm. Starting at this value, the whole cell current was measured by depolarizing or hyperpolarizing Vc in steps of 10 mV to 640 mV. Gm was calculated from the measured whole cell current (I) and Ga and Vc by using Kirchhoff’s and Ohm’s laws (11). Expression of AAT mRNA in mouse podocytes. The RNA preparation and RT- PCR were performed according to the method recently described (12). In brief, total RNA from cultured mouse podocytes was isolated with guanidinium/ acid phenol/chloroform extraction, and the amount of RNA was measured by spectrophotometry. For first-strand synthesis, 10 ng/µl of total RNA from podocytes were mixed in 13 RT buffer and completed with 0.5 mM dNTP, 10 µM random hexanucleotide primer, 10 mM dithiothreitol, 0.02 U RNAse inhibitor/ng RNA, and 100 U Moloney murine leukemia virus RT/µg RNA (RT was omitted in some experiments to control for amplification of contaminating DNA). RT was performed at 42°C for 1 h, followed by a denaturation at 95°C for 5 min. PCR was performed in duplicates in a total volume of 20 µl, each containing 4 µl of RT reaction and 12 µl of PCR master mixture. The mixture was overlaid with mineral oil and heated for 1 min at 94°C. The samples were kept at 80°C until 4 µl starter mixture, containing 10 pM each of sense and antisense primer and 1 U Taq DNA polymerase, were added. The cycle profile included denaturation of 1 min at 94°C, annealing for 1 min at 60°C, and extension for 1 min at 72°C. Thirty to thirty-five cycles were performed to amplify AAT DNA products. The amplification products of 10 µl of each PCR reaction were separated on a 1.5% agarose gel, stained with ethidium bromide (0.5 µg/ml), and visualized by ultraviolet irradiation. Primers were selected from sequences that have been deposited in the National Institutes of Health/National Center for Biological Information (NCBI) database. The NCBI accession numbers of the respective nucleotide sequences appear first, and in some cases, second, in parentheses: 1) mouse neutral AA transporter mASCT1 (U75215; f-ACGCAGGACAGATTTTCACC, r-TGGCTTCCACCTT-CACTTCT; product size: 313 bp); 2) mouse mASCT2 (D85044; f-CCTCCAATCTGGTGTCTGCT, r-CCGTTTAGTTGTGCGATGAA; product size: 673 bp); 3) human hB (AA308071; f-CGCCTCTGAGAAG- AMINO ACID TRANSPORT IN PODOCYTES F1001 Fig. 1. RT-PCR studies with primers derived from mouse DNA sequences amplified mRNA for neutral amino acid transport (AAT) systems ASCT1, ASCT2, IAT, and B0/1, cationic AAT systems CAT1 and CAT3, and anionic AAT systems EAAT2 and EAAT3 (1–11). Experiments were performed by using RT (RT1) or no RT (RT2) in each setup. Fig. 2. Original recording of effect of 5 mM alanine (Ala) on membrane voltage (Vm; A) and membrane conductance (Gm; B) of a podocyte. Addition of Ala leads to reversible depolarization and conductance increase. derivate mAIB depolarize podocytes in a concentrationdependent manner. In contrast, BCH, an agonist of system L, had no effect. Extracellular Na1 concentration ([Na1]e) dependence of AAT in podocytes. Figure 5A shows the effect of Ala in the presence and absence of extracellular Na1. Deple- Fig. 3. Concentration-response curves of effect of different amino acids (A–C) on Vm of podocytes. n, No. of experiments. Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 proline (Pro), glycine (Gly), serine (Ser), threonine (Thr), cysteine (Cys), asparagine (Asn), and glutamine (Gln), the acidic AA glutamic acid (Glu), and the basic AA arginine (Arg) and histidine (His) depolarized podocytes and increased Gm in a concentration-dependent manner. The estimated Km values for the depolarization were calculated as follows (in mM): 0.2 Ala, 2.5 Gly, 4.0 Leu, 0.5 Met, 9.0 Phe, 0.7 Pro, 0.3 Cys, 0.3 Ser, 4.0 Thr, 0.7 Asn, 1.2 Gln, 6.0 His, 0.1 Arg, and 25.0 Glu. Compared with the neutral AA and His the depolarization induced by 10 mM Arg was relatively weak (8 6 1 mV, n 5 11). Only higher concentrations of Glu ($10 mM, n 5 5) induced a significant depolarization, whereas aspartate in a concentration up to 10 mM did not have any effect. With all AA except Arg and Asp a significant increase in Gm was observed, with a peak increase ranging from 7 6 4 (Phe, 50 mM) to 65 6 25% (Ala, 1 mM). The maximal depolarization and conductance increase obtained with different AA are summarized in Table 1. Figure 4 summarizes the effects of experiments with aminoisobutyric acid (AIB), methyl-aminoisobutyric acid (mAIB), and bicyclic amino acid 2-aminobicyclo (2,2,1 heptane)-2-carboxylic acid (BCH). Like AA, the AAT system A-specific agonist AIB and its methyl F1002 AMINO ACID TRANSPORT IN PODOCYTES Table 1. Maximal depolarization and maximal conductance increase obtained with different amino acids Maximal Amino Depolarization, Acid mV 41 6 2 40 6 4 29 6 5 28 6 3 36 6 9 55 6 7 47 6 4 34 6 4 43 6 4 45 6 4 40 6 4 861 42 6 8 23 6 6 2 6 2 (NS) 65 6 25 (1 mM) 26 6 6 (10 mM) 24 6 7 (10 mM) 7 6 4 (50 mM) 32 6 8 (5 mM) 63 6 9 (5 mM) 54 6 28 (10 mM) 50 6 19 (10 mM) 53 6 16 (1 mM) 43 6 8 (50 mM) 17 6 4 (5 mM) 3 6 4 (10 mM) 26 6 4 (10 mM) 15 6 11 (50 mM) 22 6 2 (10 mM) Km for Depolarization, Na1 Dependence mM 0.2 0.5 4.0 9.0 0.7 2.5 0.3 4.0 0.3 0.7 1.2 0.1 6.0 25.0 Yes ND Yes ND Yes Yes ND ND ND ND Yes No Partly Yes ND Values are means 6 SE. Km , Michaelis-Menten coefficient; Ala, alanine; Met, methionine; Leu, leucine; Phe, phenylalanine; Pro, proline; Gly, glycine; Ser, serine; Thr, threonine; Cys, cysteine; Asn, asparagine; Gln, glutamine; Arg, arginine; His, histidine; Glu, glutamic acid; Asp, aspartic acid; ND, not done. tion of extracellular Na1 by substitution of Na1 by 145 mM NMDG1 led to a transient hyperpolarization of podocytes from 264 6 1 to 276 6 2 mV (n 5 36). In the absence of Na1, the depolarization and the increase of Gm induced by 5 mM Ala was completely and reversibly inhibited (n 5 7). Figure 5B summarizes the effect of different AA in the absence of Na1. Similar to Ala, the depolarization induced by Gln (5 mM), Gly (5 mM), Leu (5 mM), and Glu (25 mM) was abolished in the absence of extracellular Na1 and the depolarization induced by Pro (5 mM) was inhibited by .90% (n 5 5 for all). The depolarization induced by 5 mM His was only partly inhibited by ,50%, and the depolarization induced by 10 mM Arg was not significantly influenced after depletion of [Na1]e. The conductance increase induced by the AA Gln, Gly, Leu, Pro, Ala (5 mM each, n 5 4–7), and Glu (25 mM, n 5 3) were significantly inhibited in the absence of extracellular Na1 [from 65 6 21 (Leu) to 96 6 14% (Pro)]. Fig. 4. Effect of aminoisobutyric acid (AIB; left), methyl aminoisobutyric acid (mAIB; middle), and bicyclic amino acid 2-aminobicyclo (2,2,1 heptane)-2-carboxylic acid (BCH; right) on Vm of podocytes. Amino acid transport system A-specific agonists AIB and mAIB depolarize podocyte concentration dependently. On the contrary, BCH, an agonist of system L, has no effect. Nos. in brackets, no. of experiments.* Statistical significance, P , 0.05. Fig. 5. A: original recording of effects of 5 mM Ala on Vm of single podocyte in presence (145 mM) and absence (0 mM) of Na1. Note that depolarization induced by Ala was completely and reversibly inhibited in absence of extracellular Na1. B: summary of depolarizing effects of different AA in absence and presence of extracellular Na1 (n 5 3–13 experiments). Paired experiments were performed as demonstrated in Fig. 5A. Depolarization induced by Ala (5 mM), glutamine (Gln; 5 mM), glycine (Gly; 5 mM), leucine (Leu; 5 mM), proline (Pro; 5 mM), and glutamate (Glu; 25 mM) was abolished in absence of extracellular Na1, whereas arginine (Arg; 10 mM) and histidine (His; 5 mM) depolarized equally or partly. * Statistical significance, P , 0.05. Pretreatment with PA inhibits AAT in podocytes. Addition of 100 µg/ml PA to the bath solution did not significantly change resting Vm during 5–10 min (n 5 3, data not shown). Pretreatment of podocytes with 100 µg/ml for 24 h slightly decreased the resting Vm of podocytes from 264 6 1 to 254 6 2 mV (n 5 24). Figure 6 shows an original experiment of the effect of 5 mM Ala on Vm and Gm in a PA-treated podocyte. After 24-h incubation with PA the depolarization and the increase of Gm induced by Ala were almost completely inhibited (n 5 5). Figure 7 summarizes the effects of different AA on Vm and Gm in PA-treated podocytes. Similar to Ala, the depolarization and the Gm increase induced by Gln (5 mM, n 5 5), Gly (5 mM, n 5 5), Leu (5 mM, n 5 5), Pro (5 mM, n 5 5), Arg (10 mM, n 5 5), His (5 mM, n 5 7), and Glu (25 mM, n 5 5) were significantly inhibited. DISCUSSION AAT in podocytes. Uptake of AA via membrane AA transporters is essential for many cellular functions. It Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 Ala Met Leu Phe Pro Gly Ser Thr Cys Asn Gln Arg His Glu Asp Maximal Conductance Increase, % AMINO ACID TRANSPORT IN PODOCYTES is achieved by either coupling the uptake of AA to the cotransport of Na1 (secondary active transport) or by the negative cell membrane potential that is used as a driving force (26). Under physiological conditions plasma concentration of all free AA is ,2.5 mM, and a daily load of ,450 mmol of AA passes the glomerular filtration barrier. During proteinuric states, however, this amount may be strongly increased and not only tubular cells but also podocytes are faced with much higher concentrations of AA due to hydrolysis of oligopeptides within the Bowman’s space (29). Disturbance of AAT has been assumed in podocyte damage in Fig. 7. Summary of inhibitory effects of an incubation of podocytes with PA (100 µg/ml for 24 h) on amino acid-induced depolarization (A) and conductance increase (B). Note that amino acid-induced depolarization and increase of whole cell conductance were significantly inhibited. cystinosis, suggesting that AAT might play a role in the maintenance of podocyte function (32). Here, we demonstrate active AAT in mouse podocytes and mRNA expression for several AA uptake transporters such as the neutral AAT systems ASCT1, ASCT2, IAT, and B0/1, the cationic AAT systems CAT1 and CAT3, and the anionic AAT systems EAAT2 and EAAT3. All AAT detected in cultured podocytes could also be identified in isolated mouse glomerula, suggesting that these systems are also present in vivo. Patch-clamp studies showed that neutral AA and L-glutamate led to a concentration- and [Na1]e-dependent depolarization and conductance increase in podocytes, with Km values very similar to rat kidney proximal tubule cells (16, 28). Depolarization was also induced by the specific substrates AIB and mAIB, indicating that mouse podocytes also possess the widely distributed AAT system A for uptake of small neutral AA, the cDNA code of which has not yet been cloned (17). System A AAT has been reported to be involved in cell volume and osmolyte regulation (4, 6, 17), which may be essential for podocyte function during physiological states and proteinuric diseases. Podocytes also express Na1-dependent neutral AA transporters ASCT1 and ASCT2, which are distributed in a wide variety of cell types and are structurally related to glutamate transporters (5, 26). ASCT1 transports Ala, Ser, Thr, Cys, and Val, whereas ASCT2 has a broader substrate selectivity; i.e., it also accepts AA with longer side chains such as Glu and Met (3, 17). The presence of the cationic AAT systems CAT1, CAT2, and CAT3 allows the Na1-independent uptake of basic and dibasic AA (Arg, Lys, Orn, and Hist) (8). Podocytes seem to express CAT1 and CAT3 but not CAT2. However, expression of all three CAT transporters was detected in glomerula, indicating that CAT2 is expressed in other glomerular cells. In this regard it has been shown that within rat glomerula CAT2 is expressed in parietal cells of Bowman’s capsule (2). Interestingly, CAT3 has been suggested to be brain specific (8) with a Km for Arg that is similar to the Km observed in podocytes in this study (0.1 mM). CAT3 mRNA has been demonstrated in rat neurons but not in glial or brain endothelial cells (15). The relatively small depolarization induced by Larginine suggests the existence of a Na1-independent membrane transport of L-arginine. In the absence of extracellular Na1, the depolarization induced by the dibasic AA His was inhibited by ,50%, suggesting that His might also be transported via the Na1-dependent, broad-scope AA transporter B0/1, which accepts dibasic and some neutral AA. Alternatively, His transport might have been inhibited by NMDG1. The examination of acidic AAT was limited due to the solubility of glutamate and aspartate at a pH of 7.4. In higher concentrations (Km 5 25 mM) glutamate also depolarized podocytes, indicating that glutamate uptake might occur via the anionic AAT EAAT2 and EAAT3. EAAT2 has been assumed to be specifically expressed in the brain, where it has been demonstrated in astrocytes (17). EAAT3 expression has been demon- Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 Fig. 6. Influence of 5 mM Ala on Vm (A) and Gm (B) of podocyte after preincubation for 24 h with 100 µg/ml puromycin aminonucleoside (PA). Note that Ala-induced depolarization and its effect on Gm were strongly attenuated compared with control cells (see Fig 2). F1003 F1004 AMINO ACID TRANSPORT IN PODOCYTES We thank Temel Kilic, Charlotte Hupfer, and Monika von Hofer for excellent technical assistance. We also thank Bernd Friedrich and Wilfried Benz from ASTRA GMBH, Hamburg, Germany, for financial support. This work was supported by the Forschungskommission der Universität Freiburg. Address for reprint requests and other correspondence: H. Pavenstädt, Medizinische Universitätsklinik, Abt. Nephrologie, Hugstetter- str. 55, D-79106 Freiburg, Germany (E-mail: [email protected]). Received 28 April 1999; accepted in final form 30 December 1999. REFERENCES 1. Aoki E and Takeuchi IK. Immunhistochemical localization of arginine and citrulline in rat renal tissue. J Histochem Cytochem 45: 875–881, 1997. 2. Burger-Kentischer A, Müller E, Klein HG, Schober A, Neuhöfer W, and Beck FX. Cationic amino acid transporter mRNA expression in rat kidney and liver. Kidney Int 67: S136– S138, 1998. 3. Bussolati O, Laris PC, Rotoli BM, Dall’Asta V, and Gazzola GC. Transport system ASC for neutral amino acids. J Biol Chem 267: 8330–8335, 1992. 4. Bussolati O, Uggeri J, Belletti S, Dall’Asta V, and Gazzola GC. The stimulation of Na, K, Cl cotransport and of system A for neutral amino acid transport is a mechanism for cell volume increase during the cell cycle. FASEB J 10: 920–926, 1996. 5. Castagna M, Shayakul C, Trotti D, Sacchi F, Harvey WR, and Hediger MA. Molecular characteristics of mammalian and insect amino acid transporters: implications for amino acid homeostasis. J Exp Biol 200: 269–286, 1997. 6. Chen JG, Coe M, McAteer JA, and Kempson SA. Hypertonic activation and recovery of system A amino acid transport in renal MDCK cells. Am J Physiol Renal Fluid Electrolyte Physiol 270: F419–F424, 1996. 7. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70: 43–77, 1990. 8. Deves R and Boyd CAR. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78: 487–545, 1998. 9. Diamond JR, Bonventre JV, and Karnovsky MJ. A role for oxygen radicals in aminonucleoside nephrosis. Kidney Int 29: 478–483, 1986. 10. Gloy J, Henger A, Fischer K-G, Nitschke R, Mundel P, Bleich M, Schollmeyer P, Greger R, and Pavenstädt H. Angiotensin II depolarizes podocytes in the intact glomerulus of the rat. J Clin Invest 99: 2772–2781, 1997. 11. Greger R and Kunzelmann K. Simultaneous recording of the cell membrane potential and properties of the cell attached membrane of HT29 colon carcinoma and CF-PAC cells. Pflügers Arch 391: 209–211, 1991. 12. Greiber S, Münzel T, Kästner S, Müller B, Schollmeyer P, and Pavenstädt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int 53: 654–663, 1998. 13. Gwinner W, Landmesser U, Brandes RP, Kubat B, Plasger J, Eberhard O, Koch KM, and Olbricht CJ. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 8: 1722–1731, 1997. 14. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ. Improved patch-clamp technique for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85–100, 1981. 15. Hosokawa H, Ninomiya H, Sawamura T, Sugimoto Y, Ichikawa A, Fujiwara K, and Masaka T. Neuron-specific expression of cationic amino acid transporter 3 in the adult brain. Brain Res 838: 158–165, 1999. 16. Hoyer J and Gögelein H. Sodium-alanine cotransport in renal proximal tubule cells investigated by whole-cell current recording. J Gen Physiol 97: 1073–1094, 1991. 17. Kanai Y. Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications. Curr Op Cell Biol 9: 565–572, 1997. 18. Kerjaschki D. Dysfunctions of cell biological mechanisms of visceral epithelial cells (podocytes) in glomerular disease. Kidney Int 45: 300–313, 1994. 19. Kriz W, Hackenthal E, Nobiling R, Sakai T, and Elger M. A role for podocytes to counteract capillary wall distension. Kidney Int 45: 369–376, 1994. Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 strated in neurons, but it is also expressed in different peripheral cells, such as in epithelial cells of the intestine (17). As demonstrated in the present study there is a strong concentration-dependent depolarization in podocytes induced by AA, reflecting secondary active AAT for most neutral AA with Km values ranging from 0.1 to 10 mM. Thus it is apparent that a relatively small increase in AA concentration within the Bowman’s space during proteinuric states or a protein-rich diet would lead to a relatively strong increase in depolarization, due to increased uptake of AA and Na1 in podocytes. PA nephrosis (PAN) is an experimental rat model of human minimal-change disease (33). Both diseases are characterized by nephrotic range proteinuria and podocyte foot process effacement as the morphological hallmark (18). The precise mechanisms underlying podocyte damage in PAN are not well known, but the foot process effacement is associated with a disaggregation and rearrangement of actin filaments and induction of a-actinin (31, 34). After 24-h treatment with PA Vm was only slightly decreased, indicating that PA did not markedly alter resting ion currents in podocytes. However, after PA treatment, AA-induced depolarization and conductance increase were markedly inhibited, suggesting that PAN-induced injury of podocytes is associated with a decrease in AAT. Altered AA transport by PA may induce podocyte injury by several distinct mechanisms. For example, inhibition of cysteine transport by PA may lead, via reduction of intracellular glutathione levels (7), to an imbalance of antioxidant defense mechanisms in podocytes. Oxidative stress has been assumed to play a major role in aminonucleoside nephrosis, (9) and a disturbance of intrinsic antioxidant defense mechanisms in PAN participates in podocyte injury (13). Alternatively, PA-induced disturbance of Arg uptake may change the Arg-dependent synthesis of nitric oxide and other important second messengers. The highest amount of intracellular Arg within the glomerulus has been localized in podocytes (1). This may play a critical role in podocyte function because dietary intervention with L-arginine improves proteinuria and may reduce podocyte damage during proteinuric states like PAN (27). In conclusion, we have shown that differentiated podocytes express distinct functional transporters for AA uptake. AAT in podocytes was inhibited by PA, suggesting that it is altered during podocyte injury in this model of proteinuric disease. These findings suggest that normal function of AA transporters may play a role in maintaining the differentiated cytoarchitecture of podocytes. AMINO ACID TRANSPORT IN PODOCYTES 27. Reyes AA, Karl IE, and Klahr S. Role of arginine in health and in renal disease. Am J Physiol Renal Fluid Electrolyte Physiol 267: F331–F346, 1994. 28. Samarzija I and Frömter E. Electrophysiological analysis of rat renal sugar and amino acid transport. Pflügers Arch 393: 199–209, 1982. 29. Silbernagl S. The renal handling of amino acids and oligopeptides. Physiol Rev 68: 911–1007, 1988. 30. Simons M, Saffrich R, Reiser J, and Mundel P. Directed membrane transport is involved in process formation in cultured podocytes. J Am Soc Nephrol 10: 1633–1639, 1999. 31. Smoyer WE, Mundel P, Gupta A, and Welsh MJ. Podocyte a-actinin induction precedes foot process effacement in experimental nephrotic syndrome. Am J Physiol Renal Physiol 273: F150– F157, 1997. 32. Spear G. The proximal tubule and the podocyte in cystinosis. Nephron 10: 57–60, 1973. 33. Vernier RL, Papermaster BW, and Good RA. Aminonucleoside nephrosis. I. Electron microscope study of the renal lesions in rats. J Exp Med 109: 115–126, 1959. 34. Whiteside CI, Cameron R, Munk S, and Levy J. Podocytic cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis. Am J Pathol 142: 1641–1653, 1993. Downloaded from http://ajprenal.physiology.org/ by 10.220.32.247 on May 4, 2017 20. Law RO. An inwardly-directed sodium-amino acid cotransporter influences steady-state cell volume in slices of rat renal papilla incubated in hyperosmotic media. Pflügers Arch 413: 43–50, 1988. 21. Lin G, McCormick JI, and Johnstone RM. Differentiation of two classes of ‘‘A’’ system amino acid transporters. Arch Biochem Biophys 312: 308–315, 1994. 22. Lorenz C, Pusch M, and Jentsch TJ. Heteromultimeric CLC chloride channels with novel properties. Proc Natl Acad Sci USA 93: 13362–13366, 1996. 23. Malandro MS and Kilberg MS. Molecular biology of mammalian amino acid transporters. Annu Rev Biochem 65: 305–336, 1996. 24. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker CB, and Verrey F. Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395: 288–291, 1998. 25. Mundel P, Reiser J, Borja AZ, Pavenstädt H, Davidson GR, Kriz W, and Zeller RR. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248–258, 1997. 26. Palacin M, Estevez R, Bertran J, and Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 78: 969–1054, 1998. F1005